Ameritas Investment Partners’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,359
Closed -$626K 3146
2025
Q2
$626K Sell
6,359
-202
-3% -$19.1K 0.02% 760
2025
Q1
$608K Sell
6,561
-134
-2% -$12.4K 0.02% 745
2024
Q4
$608K Hold
6,695
0.02% 755
2024
Q3
$646K Sell
6,695
-246
-4% -$24K 0.02% 751
2024
Q2
$637K Sell
6,941
-378
-5% -$35.1K 0.02% 731
2024
Q1
$675K Hold
7,319
0.02% 732
2023
Q4
$696K Hold
7,319
0.03% 710
2023
Q3
$684K Sell
7,319
-818
-10% -$75.6K 0.03% 681
2023
Q2
$744K Sell
8,137
-8,306
-51% -$681K 0.03% 672
2023
Q1
$1.21M Buy
16,443
+8,100
+97% +$701K 0.05% 503
2022
Q4
$800K Sell
8,343
-7,900
-49% -$712K 0.03% 656
2022
Q3
$1.57M Buy
16,243
+799
+5% +$95.3K 0.07% 326
2022
Q2
$1.62M Hold
15,444
0.07% 336
2022
Q1
$2.66M Hold
15,444
0.1% 221
2021
Q4
$2.5M Hold
15,444
0.08% 256
2021
Q3
$2.3M Sell
15,444
-160
-1% -$33.3K 0.08% 257
2021
Q2
$3.82M Sell
15,604
-264
-2% -$69.3K 0.14% 127
2021
Q1
$4.39M Hold
15,868
0.17% 87
2020
Q4
$4.65M Sell
15,868
-124
-0.8% -$31.8K 0.21% 73
2020
Q3
$3.78M Sell
15,992
-175
-1% -$39.8K 0.17% 93
2020
Q2
$3.21M Sell
16,167
-2,462
-13% -$459K 0.15% 110
2020
Q1
$3.42M Sell
18,629
-9
-0% -$1.6K 0.19% 79
2019
Q4
$3.11M Sell
18,638
-1,170
-6% -$174K 0.14% 132
2019
Q3
$2.6M Buy
19,808
+469
+2% +$61.1K 0.12% 171
2019
Q2
$2.35M Buy
19,339
+8,559
+79% +$1.02M 0.11% 195
2019
Q1
$1.33M Buy
10,780
+8,560
+386% +$1.07M 0.06% 388
2018
Q4
$260K Buy
2,220
+125
+6% +$14.7K 0.01% 859
2018
Q3
$262K Sell
2,095
-186
-8% -$20.5K 0.01% 941
2018
Q2
$195K Sell
2,281
-134
-6% -$9.84K 0.01% 1080
2018
Q1
$146K Hold
2,415
0.01% 1257
2017
Q4
$127K Hold
2,415
0.01% 1362
2017
Q3
$126K Hold
2,415
0.01% 1317
2017
Q2
$152K Hold
2,415
0.01% 1201
2017
Q1
$123K Buy
+2,415
New +$115K 0.01% 1307

Other funds holding AMED

Ameritas Investment Partners's AMED Position: Q3 2025 in Review

Ameritas Investment Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,359 shares — an estimated $626K sold.

Ameritas Investment Partners first reported a position in AMED in Q1 2017 and held it in 34 quarters. The position peaked at $4.65M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Ameritas Investment Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 6,359 Amedisys shares in Q3 2025, an estimated $626K.
  • Ameritas Investment Partners first reported a position in Amedisys in Q1 2017 and held it in 34 quarters.
  • Ameritas Investment Partners's Amedisys position peaked at $4.65M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Ameritas Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.